- Home
- INM vs CNSP Comparison
INM vs CNSP Comparison
Compare INM & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- CNSP
- Stock Information
- Founded
- INM 1981
- CNSP 2017
- Country
- INM Canada
- CNSP United States
- Employees
- INM N/A
- CNSP N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- CNSP Health Care
- Exchange
- INM Nasdaq
- CNSP Nasdaq
- Market Cap
- INM 4.1M
- CNSP 4.0M
- IPO Year
- INM N/A
- CNSP 2019
- Fundamental
- Price
- INM $1.70
- CNSP $6.04
- Analyst Decision
- INM
- CNSP Strong Buy
- Analyst Count
- INM 0
- CNSP 1
- Target Price
- INM N/A
- CNSP $20.00
- AVG Volume (30 Days)
- INM 61.5K
- CNSP 18.2K
- Earning Date
- INM 11-06-2025
- CNSP 11-12-2025
- Dividend Yield
- INM N/A
- CNSP N/A
- EPS Growth
- INM N/A
- CNSP N/A
- EPS
- INM N/A
- CNSP N/A
- Revenue
- INM $4,798,116.00
- CNSP N/A
- Revenue This Year
- INM N/A
- CNSP N/A
- Revenue Next Year
- INM N/A
- CNSP N/A
- P/E Ratio
- INM N/A
- CNSP N/A
- Revenue Growth
- INM N/A
- CNSP N/A
- 52 Week Low
- INM $1.56
- CNSP $4.93
- 52 Week High
- INM $8.27
- CNSP $114.00
- Technical
- Relative Strength Index (RSI)
- INM 36.70
- CNSP 42.25
- Support Level
- INM $1.59
- CNSP $6.13
- Resistance Level
- INM $1.91
- CNSP $8.86
- Average True Range (ATR)
- INM 0.10
- CNSP 0.62
- MACD
- INM 0.00
- CNSP -0.10
- Stochastic Oscillator
- INM 29.47
- CNSP 27.93
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.